全文获取类型
收费全文 | 768篇 |
免费 | 51篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 14篇 |
妇产科学 | 7篇 |
基础医学 | 75篇 |
口腔科学 | 2篇 |
临床医学 | 103篇 |
内科学 | 203篇 |
皮肤病学 | 4篇 |
神经病学 | 89篇 |
特种医学 | 104篇 |
外科学 | 84篇 |
综合类 | 20篇 |
一般理论 | 1篇 |
预防医学 | 48篇 |
眼科学 | 32篇 |
药学 | 56篇 |
中国医学 | 3篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 11篇 |
2022年 | 11篇 |
2021年 | 20篇 |
2020年 | 17篇 |
2019年 | 19篇 |
2018年 | 22篇 |
2017年 | 9篇 |
2016年 | 16篇 |
2015年 | 14篇 |
2014年 | 18篇 |
2013年 | 35篇 |
2012年 | 22篇 |
2011年 | 34篇 |
2010年 | 27篇 |
2009年 | 20篇 |
2008年 | 26篇 |
2007年 | 72篇 |
2006年 | 30篇 |
2005年 | 34篇 |
2004年 | 21篇 |
2003年 | 35篇 |
2002年 | 32篇 |
2001年 | 17篇 |
2000年 | 25篇 |
1999年 | 15篇 |
1998年 | 22篇 |
1997年 | 24篇 |
1996年 | 24篇 |
1995年 | 22篇 |
1994年 | 9篇 |
1993年 | 10篇 |
1992年 | 14篇 |
1991年 | 13篇 |
1990年 | 13篇 |
1989年 | 23篇 |
1988年 | 20篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1984年 | 13篇 |
1983年 | 10篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 2篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1975年 | 2篇 |
1947年 | 1篇 |
1946年 | 1篇 |
排序方式: 共有893条查询结果,搜索用时 15 毫秒
41.
42.
Bile duct obstruction: radiologic evaluation of level, cause, and tumor resectability 总被引:6,自引:0,他引:6
Gibson RN; Yeung E; Thompson JN; Carr DH; Hemingway AP; Bradpiece HA; Benjamin IS; Blumgart LH; Allison DJ 《Radiology》1986,160(1):43-47
In a prospective study of 65 patients with bile duct obstruction, various radiologic modalities were compared for their capability to demonstrate the level and cause of obstruction and to indicate accurately tumor resectability. Ultrasound (US) was performed in 65 patients, computed tomography (CT) in 51, direct cholangiography (DC) in 57, and angiography in 35. The level of obstruction was correctly indicated by US in 95% of patients and by CT in 90%, and the cause was correctly indicated by US in 88%, by CT in 63%, and by DC in 89%. In predicting tumor resectability, US was correct in 71% of patients, compared with 42% for CT, 58% for DC, and 25% for angiography. US therefore appears to be the single most useful modality in the evaluation bile duct obstruction. 相似文献
43.
44.
Ben J. Burston Jane H. Wood James R. Lewis Gareth H. Prosser Laura Firth David J. Wood Piers J. Yates 《The Journal of arthroplasty》2014
We prospectively followed 112 hips, undergoing THA with a Spectron EF stem. At mean follow-up of 11.2 years, 21 patients had died. We obtained radiological follow-up in 99% and clinical follow-up in 100% of the surviving 91 hips. Fifty-four percent demonstrated osteolysis in at least one Gruen zone. Twenty-two hips required revision for all causes, with a further five stems radiologically loose. With endpoint being stem revision for aseptic loosening or radiological failure, survivorship at 11 years was 0.783. We believe the addition of a rougher surface finish has contributed to the high levels of osteolysis and stem failure seen with the Spectron EF. 相似文献
45.
Objective Lateral sinus thrombosis is a potentially devastating but seldom studied complication of cerebellopontine angle (CPA) tumor surgery. Systemic anticoagulation in the early postoperative period has often been avoided due to the potential risks of intracranial hemorrhage.Design Retrospective review.Setting Tertiary referral center.Main Outcome Measures The goal of this study was to identify the frequency, treatment, and outcomes in patients who develop postoperative venous sinus thrombosis following CPA tumor surgery and receive early systemic anticoagulation.Results Of 43 patients with CPA tumors, we report five patients (11.6%) with transverse and/or sigmoid sinus thrombosis following resection of the tumor, four of which were detected on routine early postoperative noncontrast computed tomography (CT) scan. The thrombosis was confirmed in all cases with CT venography or magnetic resonance venography. Affected patients had significantly larger tumors than controls and tended to undergo longer operations. These patients were treated with immediate anticoagulation (intravenous heparin, followed by Coumadin for 6 months) without complication.Conclusion Venous sinus thrombosis is an underrecognized complication of CPA surgery, but it can be diagnosed in the early postoperative period by noncontrast CT imaging. Early postoperative initiation of systemic anticoagulation appears safe and effective to prevent the progression of thrombosis and its consequences. 相似文献
46.
Background
Management of high-grade T1 (formerly T1G3) bladder cancer continues to be controversial. Should patients with T1G3 bladder cancer have an immediate radical cystectomy or should they receive intravesical bacillus Calmette-Guérin preserving bladder? Gemcitabine and cisplatin (GC) adjuvant chemotherapy may help to strike a balance between intravesical and early cystectomy. For purposes of this study, we continue to refer high-grade T1 lesion as “T1G3.”Objective
To evaluate the characteristics and the long-term outcome of GC adjuvant chemotherapy in T1G3 bladder cancer after transurethral resection of bladder tumor (TURBT).Materials and methods
We, retrospectively, reviewed 48 patients who were newly diagnosed with T1G3 bladder cancer between January 2009 and December 2012. A total of 48 patients received 4 cycles of GC adjuvant chemotherapy after TURBT. One month after 4 cycles of GC adjuvant chemotherapy, response was evaluated by re-TURBT. Median follow-up was 59.5 (range: 18–70) months, all patients have been observed for more than 3 years. Salvage cystectomy was recommended for patients with persistent disease and for tumor progression after initial complete response.Result
Complete response was achieved in 44 (91.7%) patients. Of complete responders, 5 patients experienced recurrence and 5 patients showed progression. The progression rate and disease-specific survival rate were 10.4% and 91.7% at 3 years, respectively. More than 80% of survivors preserved their bladder. Kaplan-Meier curves showed that concomitant carcinoma in situ (CIS) was the only factor that had an influence on progression-free survival (P = 0.022) and disease-specific survival (P = 0.017). Concomitant CIS was the prognostic factor for progression rate and disease-specific survival rate at 3 years (P = 0.008 and P = 0.035).Conclusion
GC adjuvant chemotherapy is a safe conservative treatment for T1G3 bladder cancer, but effective is really a phase II study. Patients with T1G3 bladder cancer with concomitant CIS should be treated more aggressively because of the high risk of progression. 相似文献47.
Richard J. van Arkel Shaaz Ghouse Piers E. Milner Jonathan R. T. Jeffers 《Journal of orthopaedic research》2018,36(5):1508-1518
Additive manufacturing offers exciting new possibilities for improving long‐term metallic implant fixation in bone through enabling open porous structures for bony ingrowth. The aim of this research was to investigate how the technology could also improve initial fixation, a precursor to successful long‐term fixation. A new barbed fixation mechanism, relying on flexible struts was proposed and manufactured as a push‐fit peg. The technology was optimized using a synthetic bone model and compared with conventional press‐fit peg controls tested over a range of interference fits. Optimum designs, achieving maximum pull‐out force, were subsequently tested in a cadaveric femoral condyle model. The barbed fixation surface provided more than double the pull‐out force for less than a third of the insertion force compared to the best performing conventional press‐fit peg (p < 0.001). Indeed, it provided screw‐strength pull out from a push‐fit device (1,124 ± 146 N). This step change in implant fixation potential offers new capabilities for low profile, minimally invasive implant design, while providing new options to simplify surgery, allowing for one‐piece push‐fit components with high levels of initial stability. © 2017 The Authors. Journal of Orthopaedic Research® Published by Wiley Periodicals, Inc. on behalf of the Orthopaedic Research Society. J Orthop Res 36:1508–1518, 2018. 相似文献
48.
49.
50.
Abby McCormack Mark Edmondson-Jones Heather Fortnum Piers Dawes Hugh Middleton Kevin J. Munro David R. Moore 《Journal of psychosomatic research》2014